To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Single injection of hyaluronic acid not recommended for ankle osteoarthritis treatment

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
August 2013

Single injection of hyaluronic acid not recommended for ankle osteoarthritis treatment

Vol: 2| Issue: 7| Number:376| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Intra-articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double-blind, placebo-controlled study

J Bone Joint Surg Am. 2012 Jan 4;94(1):2-8

Contributing Authors:
H Degroot S Uzunishvili R Weir A Al-Omari B Gomes

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

64 patients presenting with osteoarthritis of the ankle were randomized to treatment receiving a single intra-articular injection with low molecular weight, non-cross linked hyaluronic acid or saline solution. The results measured at 16 weeks indicated that the hyaluronic acid treatment provided a significant reduction in American Orthopedic Foot and Ankle Society (AOFAS) score when compared to ba...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue